BRCA1 and neoplasm: In TNBC, miR-199a 3p acts as a tumor suppressor by targeting BRCA1, impairing DNA repair, and decreasing proliferation and migration—additionally enhancing sensitivity to cisplatin and PARP inhibitors [64].